Ahmet Icigen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ahmet Icigen has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Akın Koçhan
DİCLE ÜNİVERSİTESİ, VETERİNER FAKÜLTESİ
2 shared publications - Almina Güneş
Dicle University. Sur, Diyarbakir, Turkey
2 shared publications - Aynur Simsek
DİCLE ÜNİVERSİTESİ, VETERİNER FAKÜLTESİ
2 shared publications - Murat Kaan Durgut
Department of Internal Medicine, Faculty of Veterinary Medicine, Selcuk University, Konya 42000, Turkey
2 shared publications - Pelin Fatoş Polat Dinçer
Department of Internal Medicine, Faculty of Veterinary Medicine, Dokuz Eylül University, Izmir 35400, Türkiye
2 shared publications - Ömer Faruk Katanalp
Dicle University
2 shared publications
Latest Publications
- 14 November 2025
- Published by Academician Publishing
- p. 1-62
Open AccessSindirim Sistemi Hastalıkları
- Open Access
- 14 November 2025
- Published by Academician Publishing
Veteriner Reçete-Büyük Hayvan İç Hastalıkları
- 14 November 2025
- Published by Academician Publishing
Open AccessVeteriner Reçete-Büyük Hayvan İç Hastalıkları
- Open Access
- 23 October 2025
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 13 (11) , 3328-3331
The Effects of Combination of Marbofloxacin and Ceftiofur on Serum Biochemistry in Lambs with Respiratory System Infection
In this study, the aim was to determine the effect of combination of marbofloxacin and ceftiofur on serum biochemical parameters in lambs with clinical respiratory system infection. The study included 10 Merino lambs showing symptoms of respiratory system infection in a commercial farm. Blood samples were taken from the animals before drug administration (hour 0) and 24, 48, 72, 96, and 120 hours after the first simultaneous combined drug administration (marbofloxacin 2 mg/kg, IM, once a day + ceftiofur 1 mg/kg, IM, once a day; 5 days). Serum alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and creatinine levels were measured in the autoanalyzer from the serum obtained from the samples taken, and the clinical symptoms of the animals were monitored daily. At the final sampling time (120 hours), AST, ALT, and BUN levels were found to be significantly higher (P < 0.05) compared to those at the initial sampling time (hour 0). On the second day of treatment, clinical signs (runny nose, fever, cough, etc.) and feed consumption began to improve. The combined use of ceftiofur and marbofloxacin is highly effective in the treatment of severe respiratory system infection in lambs.
- 23 October 2025
- Published by Turkish Science and Technology Publishing (TURSTEP) in Turkish Journal of Agriculture - Food Science and Technology
- Vol. 13 (11) , 3328-3331
Open AccessThe Effects of Combination of Marbofloxacin and Ceftiofur on Serum Biochemistry in Lambs with Respiratory System Infection
In this study, the aim was to determine the effect of combination of marbofloxacin and ceftiofur on serum biochemical parameters in lambs with clinical respiratory system infection. The study included 10 Merino lambs showing symptoms of respiratory system infection in a commercial farm. Blood samples were taken from the animals before drug administration (hour 0) and 24, 48, 72, 96, and 120 hours after the first simultaneous combined drug administration (marbofloxacin 2 mg/kg, IM, once a day + ceftiofur 1 mg/kg, IM, once a day; 5 days). Serum alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), blood urea nitrogen (BUN), and creatinine levels were measured in the autoanalyzer from the serum obtained from the samples taken, and the clinical symptoms of the animals were monitored daily. At the final sampling time (120 hours), AST, ALT, and BUN levels were found to be significantly higher (P < 0.05) compared to those at the initial sampling time (hour 0). On the second day of treatment, clinical signs (runny nose, fever, cough, etc.) and feed consumption began to improve. The combined use of ceftiofur and marbofloxacin is highly effective in the treatment of severe respiratory system infection in lambs.
- Open Access
- 14 October 2025
- Published by Taylor & Francis in Veterinary Quarterly
- Vol. 45 (1) , 2573815
Feline panleukopenia-associated clinicopathological abnormalities: first evaluation of diagnostic and prognostic roles of endothelial glycocalyx degradation biomarkers
The aim of this study was to investigate the role of endothelial activation and glycocalyx degradation in the pathogenesis of feline panleukopenia (FPL) using biomarkers and to determine the diagnostic and prognostic significance of these biomarkers. Thirty cats with FPL and 10 healthy cats were enrolled. Clinical examination, blood gases, and complete blood count (CBC) were performed at enrollment. Endothelin-1 (ET-1), asymmetric dimethylarginine (ADMA), vascular endothelial growth factor-A (VEGF-A), and syndecan-1 (Syn-1) concentrations were measured using feline specific commercial enzyme-linked immunosorbent assay (ELISA) kits to assess endothelial glycocalyx damage. Nineteen (63.3%) of the cats with FPL recovered and survived, while 11 (36.7%) died. In cats with panleukopenia, acidemia was the most important blood gas finding, while leukopenia, lymphopenia, monocytopenia, granulocytopenia, and thrombocytopenia were the most dominant CBC findings. ET-1, ADMA, VEGF-A, and Syn-1 concentrations were significantly higher in cats with panleukopenia (p < 0.01). Serum Syn-1 and ET-1 concentrations were found to be useful in predicting mortality. In conclusion, the fact that the concentrations of all endothelial glycocalyx biomarkers (ET-1, ADMA, VEGF-A, Syn-1) were higher in cats with panleukopenia compared to healthy cats suggests that endothelial glycocalyx damage occurs during panleukopenia infection. In addition, Syn-1 and ET-1 were found to be potential prognostic factors with high sensitivity and specificity.
- 14 October 2025
- Published by Taylor & Francis in Veterinary Quarterly
- Vol. 45 (1) , 2573815
Open AccessFeline panleukopenia-associated clinicopathological abnormalities: first evaluation of diagnostic and prognostic roles of endothelial glycocalyx degradation biomarkers
The aim of this study was to investigate the role of endothelial activation and glycocalyx degradation in the pathogenesis of feline panleukopenia (FPL) using biomarkers and to determine the diagnostic and prognostic significance of these biomarkers. Thirty cats with FPL and 10 healthy cats were enrolled. Clinical examination, blood gases, and complete blood count (CBC) were performed at enrollment. Endothelin-1 (ET-1), asymmetric dimethylarginine (ADMA), vascular endothelial growth factor-A (VEGF-A), and syndecan-1 (Syn-1) concentrations were measured using feline specific commercial enzyme-linked immunosorbent assay (ELISA) kits to assess endothelial glycocalyx damage. Nineteen (63.3%) of the cats with FPL recovered and survived, while 11 (36.7%) died. In cats with panleukopenia, acidemia was the most important blood gas finding, while leukopenia, lymphopenia, monocytopenia, granulocytopenia, and thrombocytopenia were the most dominant CBC findings. ET-1, ADMA, VEGF-A, and Syn-1 concentrations were significantly higher in cats with panleukopenia (p < 0.01). Serum Syn-1 and ET-1 concentrations were found to be useful in predicting mortality. In conclusion, the fact that the concentrations of all endothelial glycocalyx biomarkers (ET-1, ADMA, VEGF-A, Syn-1) were higher in cats with panleukopenia compared to healthy cats suggests that endothelial glycocalyx damage occurs during panleukopenia infection. In addition, Syn-1 and ET-1 were found to be potential prognostic factors with high sensitivity and specificity.